Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer


ABSTRACT: Inhibition of SET by siRNA or SET antagonist and CIP2A by siRNA can downregulate c-MYC and c-MYC target genes. Cells were treated with a SET antagonist (1μMOP449) for 12 hours, or siRNA for 48 hours.

ORGANISM(S): Homo sapiens

SUBMITTER: Rosalie Sears 

PROVIDER: E-GEOD-58008 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer.

Janghorban Mahnaz M   Farrell Amy S AS   Allen-Petersen Brittany L BL   Pelz Carl C   Daniel Colin J CJ   Oddo Jessica J   Langer Ellen M EM   Christensen Dale J DJ   Sears Rosalie C RC  

Proceedings of the National Academy of Sciences of the United States of America 20140609 25


The transcription factor c-MYC is stabilized and activated by phosphorylation at serine 62 (S62) in breast cancer. Protein phosphatase 2A (PP2A) is a critical negative regulator of c-MYC through its ability to dephosphorylate S62. By inactivating c-MYC and other key signaling pathways, PP2A plays an important tumor suppressor function. Two endogenous inhibitors of PP2A, I2PP2A, Inhibitor-2 of PP2A (SET oncoprotein) and cancerous inhibitor of PP2A (CIP2A), inactivate PP2A and are overexpressed in  ...[more]

Similar Datasets

2014-05-28 | GSE58008 | GEO
| S-EPMC4078832 | biostudies-literature
| S-EPMC5663475 | biostudies-literature
| S-ECPF-GEOD-58008 | biostudies-other
2014-04-01 | GSE54217 | GEO
2016-01-20 | E-GEOD-70487 | biostudies-arrayexpress
2014-07-01 | E-GEOD-57887 | biostudies-arrayexpress
2012-09-27 | E-GEOD-37229 | biostudies-arrayexpress
2014-04-01 | E-GEOD-54217 | biostudies-arrayexpress
| PRJNA219441 | ENA